Innovation 

Platform

Tavo Select™
Tavo Select™
Tavo Precise™
Tavo Precise™
Tavo ELITE™
Tavo ELITE™

ABOUT US

Tavotek is a biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs. Our company management and advisors consist of veteran pharmaceutical executives with multiple prior successes in the development and commercialization of many blockbuster biologics currently in the market. Tavotek has 3 diverse R&D platform for biologics: TavoSelect™ (Phage Display Library), TavoPrecise™ (Tissue-specific biologics engineering platform), and TavoELITE™ (Intracellular Undruggable Target platform). Along with these platforms, Tavotek has a rich and diverse pipeline of product candidates focused on cancers, autoimmune conditions, and infectious diseases in various stages of development. We are globally connected with operations in Asia and North America. Our development strategy includes organic growth, biopharma collaboration, and potential clinical stage asset licensing.

COMPANY

2024

2013
2019
Established in
50
11 +
Assets in Different Stages
10
25 +
Years of Big Pharma Executive Experience
2013
60 +
Qualified R&D Staff

LATEST

NEWS

05-09 2023

Tavotek Biotherapeutics Doses First Patient in Phase 1 First-in-Human Clinical Trial of TAVO412, a Multispecific Biologic for Solid Tumors

Tavotek Biotherapeutics Doses First Subject in Phase 1 First-in-Human Clinical Trial of TAVO412, a Multispecific Biologic for Solid TumorsMay 9, 2023 ....

Read More
拓创科技
Tavotek Biotherapeutics Named Finalist for 2023 Annual Awards by Life Sciences Pennsylvania
(LOWER GWYNEDD, Pennsylvania, March 15, 2023) Tavotek Biotherapeutics, a clinical-stage biopharmaceutical company focused on discovering, developing, ....
2023-03-15
拓创科技
Tavotek Biotherapeutics Attends The 41st Annual J.P. Morgan Healthcare Conference
(LOWER GWYNEDD, Pennsylvania, January 9, 2023) Tavotek Biotherapeutics, a clinical-stage biopharmaceutical company focused on discovering, developing,....
2023-01-09
imgboxbg

TavoSELECT™ Phage Library

TavoSELECT™ provides access to antibodies or biomolecules that target membrane proteins, intracellular proteins, or antigens that are more difficult to target due to the blood-brain barrier.

imgboxbg

TavoPRECISE™ Platform

TavoPRECISE™ is a Fit-for-Purpose monoclonal antibody and multi-specific biologics development platform.

imgboxbg

TavoELITE™ Platform

TavoELITE™, a novel platform that goes after intracellular targets for the treatment of cancer and other diseases.

 

727 Norristown Road, 3 Spring House Innovation Park Suite 101, Lower Gwynedd, Pennsylvania 19002

China. Suzhou. Suzhou Industrial Park. Unit 405, Building C2, No. 218, Xinghu Street

© 2023 Tavotek Biotherapeutics All rights reserved.   (267) 405-9426

© 2023 Tavotek Biotherapeutics All rights reserved.(267) 405-9426